Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Invest Surg ; 30(1): 33-40, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27715338

RESUMEN

AIM OF THE STUDY: To investigate the pulmonary oxidative stress and possible protective effect of N-Acetylcysteine (NAC) and Desferoxamine (DFX)in a porcine model subjected to hemorrhagic shock. MATERIALS AND METHODS: Twenty-one pigs were randomly allocated to Group-A (sham, n = 5), Group-B (fluid resuscitation, n = 8) and Group-C (fluid, NAC and DFX resuscitation, n = 8). Groups B and C were subjected to a 40-min shock period induced by liver trauma, followed by a 60-min resuscitation period. During shock, the mean arterial pressure (MAP) was maintained at 30-40 mmHg. Resuscitation consisted of crystalloids (35 mL/kg) and colloids (18 mL/kg) targeting to MAP normalization (baseline values ± 10%). In addition, Group-C received pretreatment with NAC 200 mg/kg plus DFX 2 g as intravenous infusions. Thiobarbituric Acid Reactive Substances (TBARS), protein carbonyls and glutathione peroxidase (GPx) activity were determined in lung tissue homogenates. Also, histological examination of pulmonary tissue specimens was performed. RESULTS: TBARS were higher in Group-B than in Group-A or Group-C: 2.90 ± 0.47, 0.57 ± 0.10, 1.78 ± 0.47 pmol/µg protein, respectively (p < 0.05). Protein carbonyls content was higher in Group-B than in Group-A or Group-C: 3.22 ± 0.68, 0.89 ± 0.30, 1.95 ± 0.54 nmol/mg protein, respectively (p > 0.05). GPx activity did not differ significantly between the three groups (p > 0.05). Lung histology was improved in Group-C versus Group-B, with less alveolar collapse, interstitial edema and inflammation. CONCLUSION: NAC plus DFX prevented the increase of pulmonary oxidative stress markers and protein damage after resuscitated hemorrhagic shock and had beneficial effect on lung histology. NAC/DFX combination may be used in the multimodal treatment of hemorrhagic shock, since it may significantly prevent free radical injury in the lung.


Asunto(s)
Acetilcisteína/uso terapéutico , Deferoxamina/uso terapéutico , Depuradores de Radicales Libres/uso terapéutico , Pulmón/metabolismo , Estrés Oxidativo/efectos de los fármacos , Choque Hemorrágico/tratamiento farmacológico , Sideróforos/uso terapéutico , Acetilcisteína/administración & dosificación , Animales , Biomarcadores/análisis , Coloides , Soluciones Cristaloides , Deferoxamina/administración & dosificación , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Fluidoterapia/métodos , Glutatión Peroxidasa/análisis , Humanos , Infusiones Intravenosas , Soluciones Isotónicas/administración & dosificación , Pulmón/enzimología , Pulmón/patología , Masculino , Carbonilación Proteica/efectos de los fármacos , Distribución Aleatoria , Soluciones para Rehidratación/administración & dosificación , Choque Hemorrágico/complicaciones , Porcinos , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis
2.
Expert Rev Anticancer Ther ; 12(10): 1347-57, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23176622

RESUMEN

The incidence of hepatocellular carcinoma (HCC) has been rising in several western low-incidence areas over the past decade. The purpose of this review was to summarize the current knowledge on the 'state of the art' management of HCC focusing on targeted systemic therapies. The information for this review was compiled by searching the PubMed and MEDLINE databases for articles published until 1 June 2012. Cytotoxic chemotherapy has failed to affect outcome of HCC. Treatment with sorafenib is associated with survival gain in HCC but the responses are not durable. In addition, sorafenib is associated with substantial dermatologic and gastrointestinal toxicity. In this review, the authors summarize molecular targets and signal transduction pathways in HCC and provide an update of published and ongoing studies. Many targeted agents against angiogenesis, Ras/Raf/MAPK, EGF receptor, PI3K/AKT/mTOR, HGF/Met and IGF/IGF receptor are being tested in clinical trials.


Asunto(s)
Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Carcinoma Hepatocelular/tratamiento farmacológico , Neoplasias Hepáticas/tratamiento farmacológico , Niacinamida/análogos & derivados , Compuestos de Fenilurea/farmacología , Compuestos de Fenilurea/uso terapéutico , Transducción de Señal/efectos de los fármacos , Animales , Carcinoma Hepatocelular/metabolismo , Ensayos Clínicos como Asunto , Humanos , Neoplasias Hepáticas/metabolismo , Niacinamida/farmacología , Niacinamida/uso terapéutico , Ensayos Clínicos Controlados Aleatorios como Asunto , Sorafenib
3.
World J Surg Oncol ; 9: 149, 2011 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-22085420

RESUMEN

Permanent or temporary hypoparathyroidism may be a debilitating result of radical cervical surgery, as noted most commonly following thyroid or parathyroid surgery. However, it can also be the outcome of any surgical procedure involving bilateral extensive manipulation of the anterior neck triangle, especially in order to ensure oncologically adequate surgical margins. We report our experience of three patients that underwent parathyroid immediate autotransplanation following extensive surgical manipulations of the neck region for oncological reasons. PTH levels were restored to normal by the fourth postoperative week, allowing us to wean the patients off calcium and vitamin D3 supplementation, which was attributed to full autograft function. Parathyroid autotransplantation, immediate or delayed, is a simple and safe technique which should be considered by the surgeon whenever there is a high risk for postoperative hypoparathyroidism following radical operations of the neck for oncological reasons.


Asunto(s)
Neoplasias Esofágicas/cirugía , Hipoparatiroidismo/terapia , Glándulas Paratiroides/trasplante , Anciano , Neoplasias Esofágicas/complicaciones , Femenino , Humanos , Hipoparatiroidismo/etiología , Masculino , Persona de Mediana Edad , Hormona Paratiroidea/sangre , Complicaciones Posoperatorias , Pronóstico , Trasplante Autólogo
4.
Int Surg ; 88(2): 100-4, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12872904

RESUMEN

Life-threatening hypophosphatemia has been reported after major liver resections with a significant impact on postoperative outcome. Regeneration of the liver may play a crucial role, but the underlying mechanism has not yet been elucidated. This study aims at assessing the effect of vascular control and resected volume of the liver on postoperative phosphorus levels. The study included 30 patients that underwent liver resection. Sixteen patients were operated on without any vascular control and 14 with selective vascular exclusion. Correlation between serum kinetics of phosphorus to resected liver volume and warm ischemia was carried out. All patients experienced low postoperative phosphorus levels. The lowest levels were observed on the second postoperative day, when 40% developed life-threatening hypophosphatemia (< or = 1.1 mg/dl). Warm ischemia and major resections aggravated hypophosphatemia compared with patients operated on without vascular occlusion and with those with minor resections. Vascular exclusion and major resections aggravate hypophosphatemia. Patients who developed hypophosphatemia < or = 1.5 mg/dl were more prone to complications and longer hospital stays compared with counterparts who had serum phosphorus levels > or = 1.6 mg/dl.


Asunto(s)
Hepatectomía/efectos adversos , Hipofosfatemia/etiología , Hipofosfatemia/mortalidad , Neoplasias Hepáticas/cirugía , Fósforo/sangre , Daño por Reperfusión/etiología , Adolescente , Adulto , Anciano , Femenino , Hepatectomía/métodos , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Daño por Reperfusión/mortalidad , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA